glp-1 news oct 21 2025 Pipeline Update: August - Prime Therapeutics How Employers Can Manage GLP-1
Description
Revising our earlier interpretation of SELECT trial data in light of new analyses
The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.
See flat-rate GLP-1 pricing and learn if Peak avoids the Price-Safety Trap with real medical oversight.
No injections
Viewed by 100+ verified physicians
